← Leaderboards
Michael J Blaha
Johns Hopkins University
$4,754,137
Attributed
$11,777,619
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,777,619 · 5
By mechanism
R01$11,183,243 · 2
R21$594,376 · 3
Top collaborators
- Kunihiro Matsushita5 shared
- Melissa Daubert4 shared
- Nicholas M. Pajewski4 shared
- Seamus Paul Whelton3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Timothy F Osborne$15,539,199
- Lewis C Becker$35,680,196
- Susan J Zieman$1,644,040
- Dan E Arking$14,689,842
- Joan Marie Bathon$16,318,293
Others in their field
Other Emerging Leaders on “Risk Factors”
- Chanza Baytop · Westat, Inc.$271,217,917
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Scott Hensley · University Of Pennsylvania$48,258,374
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Dale Sandler · Social And Scientific Systems, Inc.$41,380,317
Research focus
Risk FactorsMiddle AgeParticipantAdultPhenotypeCoronary Artery CalciumPrimary PreventionOlder PopulationElderlyCardiovascular DiseasesRisk StratificationPreventiveCardiacCardiovascular SystemHigh RiskScanningFuturePreventive TherapyMalignant NeoplasmsNational Heart, Lung, And Blood InstituteDementiaPredispositionAtherosclerosisCohort
Grant awards (13)
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$1,058,459
R01 · FY2025 · HL
30-Year Follow-up of the Coronary Artery Calcium Consortium$232,500
R21 · FY2025 · HL · contact PI
Aortic Valve Calcium Prevalence, Long-term Risk Factors, and progression to Severe Aortic Stenosis Among Persons >75 Years Old$116,250
R21 · FY2025 · HL
Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)$122,813
R21 · FY2024 · HL
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$2,244,161
R01 · FY2023 · HL
Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)$122,813
R21 · FY2023 · HL
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$2,921,424
R01 · FY2022 · HL
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$1,281,492
R01 · FY2021 · HL
Quantifying cardiovascular calcification at very old age for personalized risk classification$738,579
R01 · FY2021 · HL
Quantifying cardiovascular calcification at very old age for personalized risk classification$738,831
R01 · FY2020 · HL
Quantifying cardiovascular calcification at very old age for personalized risk classification$700,497
R01 · FY2019 · HL
Quantifying cardiovascular calcification at very old age for personalized risk classification$698,510
R01 · FY2018 · HL
Quantifying cardiovascular calcification at very old age for personalized risk classification$801,290
R01 · FY2017 · HL